Venture Capital: Funding A Fraud Case Study: Venture Capital Firm New Enterprise Associates (NEA), Incubator ExploraMed’s startups and Johnson & Johnson
UPDATED: July 3, 2019
As @US_FDA Commissioner, @ScottGottliebMD & I worked together on a number of public health priorities. That’s why I found his new position on the Board of drug giant @Pfizer to be such a tough pill to swallow. https://t.co/TXXYGyy3s4
— Elizabeth Warren (@SenWarren) July 2, 2019
UPDATED: September 5, 2017
Teleflex to buy NeoTract for up to $1.1 billion in cash and potential milestone payments
— Reuters Top News (@Reuters) December 12, 2016
UPDATED: December 13, 2016 President Elect Donald Trump is considering NEA Venture Capital Partner Dr. Scott Gottlieb to head FDA.
NEA has pathologically funded startup, healthcare, medical device, fraud that has killed, injured and cost taxpayers billions. I know because I’m the DOJ federal whistleblower who exposed NEA funding fraud at Acclarent (Johnson & Johnson owned). JNJ was ordered to pay $18 million in civil damages and former Acclarent CEO & VP of Sales were indicted, arrested, convicted and waiting sentencing for selling adulterated and misbranded medical device, funded in part by NEA. Their sentencing with Judge Allison Burroughs keeps getting pushed, and now we may understand why. Nothing like having someone who funded the medical device fraud heading the FDA to keep the good ole boys out of jail, where they belong.
Please contact your government elected officials and demand that President Elect Donald Trump put NEA venture capital partners behind bars not in cabinet positions.
UPDATED: May 2016
— NEA (@NEAVC) May 5, 2016
Companies will often change their image or name to distance from previous unethical and or illegal behavior as a means to avoid accountability per The Sociopathic Business Model™. By their own assertion the world’s largest venture capital firm, New Enterprise Associates or NEA, recently changed their logo. NEA, also by this site, is linked funding at least three healthcare startup up frauds.
January 10, 2016
Venture Capital: Funding A Fraud Case Study: Venture Capital Firm New Enterprise Associates (NEA), Incubator ExploraMed’s startups, and Johnson & Johnson.
Case Study: Proving previously undetected venture capital funded startup fraud caused the tech bubble to pop in 2008; and, fraud is is the cause today for startups underperforming post-IPO or sale.
It may take a minute for this infographic to fully download, or scroll below and click on the icon to full-screen the infographic.
Click for enlarged PDF to full screen for easier reading from smartphones. The original infographic reflects NEA’s old logo.
Please scroll to the bottom for additional information and links to each company mentioned
Venture Capital Funded Medical Device Startup Fraud
Click on the links below to unfold more information on the companies, court documents, and players involved.
Click on the link a second time to retract the information.
New Enterprise Associates
NEA-funded startups Acclarent, Gynecare & Conceptus are all linked to medical device fraud
NEA Venture Partner Josh Makower, profited from injuring tens-of-thousands of women via startup Conceptus turned Bayer’s Essure and startup Gyncare turned Johnson & Johnson, Ethicon Gynecare; and, now through NEA, BVCG, Correlation Ventures & Windam Venture Partners, Josh Makower is also the Founder of Nuelle maker of sex toy Fiera for Her, inconsistently & contradictorily funding a product meant to help women; but, is essentially trying to profiting twice, from the same population, from creating the problem for women and then offering the solution to the problem he as a Venture Partner at NEA helped create, which on top of it all is a form of medical sexism.
Johnson & Johnson
Johnson & Johnson cuts 3,000 jobs in a bid to revive stalled medical device division.
— MedCity News (@medcitynews) January 19, 2016
Johnson & Johnson Development Corporation (JJDC) is the venture capital side to parent company Johnson & Johnson. In conjunction with NEA, JJDC is linked to Acclarent & Gynecare fraud, costing employees their jobs, patients their health or lives and shareholders and taxpayers millions. JJDC, despite a proven history of fraud, continues to work with NEA and funding ExploraMed’s other medical device startup Neotract, and (likely) EarLens, Nevro (the company IPO’d last year); and, NEA previously funded Conceptus which was bought by Bayer the maker of permanent birth control Essure, also associated with patient injury.
NEA-funded, ExploraMed incubated startup Acclarent executives William (Bill) Facteau & Patrick (Pat) Fabian were arrested and charged with 18 of fraud: Conspiracy, Securities Fraud, Wire Fraud, and Food, Drug and Cosmetic Act Violations
Facteau, Makower, Croce and Nehra all linked via NEA, ExploraMed and Acclarent. Facteau was once on the main page of NEA partners, then moved to Entrepreneur in Residence and now removed from the website entirely.
VCs look for unsophisticated medical device buyers or investors for their IPO
This is why Johnson & Johnson is consistently failing when it comes to medical devices. They understand how to profit from pharma fraud but didn’t know the difference when it came to medical devices, making both the company and the people who purchased stock, because of medical devices, unsophisticated investors. VCs profit at the expense of employees (who lost jobs), patients (who became injured), shareholders (who lost money) and taxpayers who have to fund the DOJ investigations.
Special thank you to Lana Keeton for the procurement of court documents
Makower, Nehra and Croce all NEA Partners linked to ExploraMed, Acclarent, & Neotract
Drant linked to NEA, ExploraMed, & Neotract
Bright and Facteau linked to ExploraMed, Acclarent & Neotract
Tyler Binney previously worked at Johnson & Johnson’s Cordis from 2000-2010
Tyler Binney Director at Sales at NEA-Funded ExploraMed Incubated startup Acclarent
Tyler Binney VP of US Sales at NEA-Funded ExploraMed Incubated startup NeoTract
Special thank you to Lana Keeton for the connection between the Torti Sr. & Torti Jr.
Patrick Fabian Acclarent to NxThera
Ally Bridge & Boston Scientific-funded startup allow Patrick (Pat) Fabian to remain as company’s COO (despite removing his name from the website) and the courts allow him to hire former Acclarent employees where he was charged with 18 counts of fraud. This should be a red flag to every single taxpayer.
Wilson Sonsini et al
This Case Study proves the existence The Sociopathic Business Model™ and not until Venture Capital firms like New Enterprise Associates, NEA, and Johnson & Johnson Development Corporation, JJDC, who pathologically fund medical device fraud, are held accountable by the U.S. Department of Justice who first must remove Eric Holder from Johnson & Johnson’s defense law firm Covington, will we hope to see any change in this fraudulent cycle. The cycle of encouraging, replicating and rewarding fraud, costing employees their jobs, patients their health or lives, shareholders money and costing taxpayers billions, who foot the bill for DOJ investigations into fraud.
Removal from the Board of Directors of the United States Institute of Peace upon conviction of a felony (22 U.S.C. ‘ 4605(f)(1));
Note to journalists, media & bloggers: Information not known to you prior to coming to this site requires citation or a link back to Killing My Career or The Sociopathic Business Model™. Please note: that learning the information here first and then finding other sources that support the same fact to avoiding using a lesser known source, is also unethical; and, I no problem calling out several journalists. Remember taking credit for another’s work is a characteristic from The Sociopathic Business Model™. This site is currently non-revenue streaming by design, where the currency is credibility; and, rest assured, I’m not interested in your jobs.